Manufacturing nonconformance rates ticked up this quarter. Is it your process, your supplier, or an industry-wide material problem? You're reviewing CAPA data, trying to pinpoint whether to tighten in

Here's what's happening right now: 391 new FDA recalls were issued this week, with a significant cluster in convenience kits used for dialysis maintenance. Specific examples include Medline's ADD A CATH DIALYSIS KIT (SKU ECVC8415A) and Centurion's CENTRAL LINE INSERTION TRAY (SKU DT19810), where silicone seal failures in Tego Connectors are causing occluded fluid paths and therapy delays. Health Canada added 5 more recalls, including labeling issues with Sterile Contro-Vac suction catheters.

For Operations Managers focused on supplier controls and manufacturing deviations, this signals a critical pattern: component-level failures in seals and connectors are driving recalls, not just final assembly issues. The dialysis kit recalls point directly to supplier material or workmanship problems that bypassed incoming inspection. Meanwhile, labeling errors in orthopedic implants (like Enovis's Reverse Shoulder Prosthesis) highlight process control gaps in packaging lines.

We analyzed this across 548,000+ regulatory records and found that over 60% of recent recalls trace back to supplier-provided components or labeling/packaging deviations. This isn't isolated—it's a systemic supply chain risk requiring enhanced oversight.

See how your specific product codes and suppliers compare at truemeddevice.com.